MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.bulcan.2025.02.029

Медицинская библиотека · Bulletin du cancer · 2025

[Leptomeningeal disease in breast cancer: State of the art and future directions].

Larrouquere Louis, Clement Emilie, Sunyach Marie Pierre, De Bernardi Axel, Cosset Erika, Bachelot Thomas

Аннотация на английскомСтатьяОбзорПеревод в очереди

Аннотация

Leptomeningeal disease (LMD) from breast cancer is defined by the invasion of the leptomeninges and cerebrospinal fluid (CSF) by tumor cells. Historically associated with a very poor prognosis and survival measured in weeks, their management has evolved considerably. Therapeutic advances, such as the introduction of targeted therapies, and a better understanding of the pathophysiology of LMD now enable earlier diagnosis through dedicated MRI sequences and optimized CSF analysis. The EANO-ESMO classification notably distinguishes type I LMD (cytology-positive), which carries a worse prognosis but is more sensitive to intrathecal (IT) treatments, from type II LMD (negative or uncertain cytology), often more responsive to local-regional approaches like radiotherapy. Data from large retrospective cohorts highlight the importance of combination therapies: systemic treatments, IT injections, radiotherapy, as well as early symptomatic and palliative care. This multidisciplinary approach improves median survival, now reaching several months, and can even surpass 10 months in HER2+ cases. Innovative clinical trials, such as ETIC-LM (NCT05800275) - a French phase II study evaluating the combination of IT trastuzumab, oral tucatinib, and oral capecitabine offer encouraging new strategies for patient care. Although the prognosis remains poor, recent advancements suggest a more hopeful future, providing better disease control and improved quality of life for patients with LMD from breast cancer.

Для цитирования: Larrouquere Louis, Clement Emilie, Sunyach Marie Pierre, De Bernardi Axel, Cosset Erika, Bachelot Thomas. [Leptomeningeal disease in breast cancer: State of the art and future directions].. Bulletin du cancer. 2025. DOI: 10.1016/j.bulcan.2025.02.029.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.